Ferozsons Laboratories's Total Assets for the quarter that ended in Dec. 2024 was ₨27,410 Mil.
Warning Sign:
If a company builds assets at 27.1% a year, faster than its revenue growth rate of 21.8% over the past 5 years, it means that the company may be getting less efficient.
During the past 12 months, Ferozsons Laboratories's average Total Assets Growth Rate was 29.70% per year.
During the past 3 years, the average Total Assets Growth Rate was 31.10% per year.
During the past 5 years, the average Total Assets Growth Rate was 27.10% per year.
During the past 10 years, Ferozsons Laboratories's highest 3-Year average Total Assets Growth Rate was 31.10%. The lowest was 0.90%. And the median was 17.80%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Ferozsons Laboratories's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ferozsons Laboratories (KAR:FEROZ) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Ferozsons Laboratories's Asset Turnover for the quarter that ended in Dec. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Ferozsons Laboratories Total Assets Related Terms
Thank you for viewing the detailed overview of Ferozsons Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Ferozsons Laboratories Ltd is a pharmaceutical company. It is engaged in the import, manufacture, and sale of pharmaceuticals products and medical devices. The company operates in the therapeutic areas of dermatology, anti-infective treatments, gastroenterology, hepatology, cardiology, and oncology. It manufactures tablets, capsules, syrups, suspensions, creams, and ointments. It operates in three segments namely Ferozsons; BF Biosciences; and Others. The group sells its products in Pakistan and internationally, of which the majority of the revenue is generated from the sales made in Pakistan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
KAR:FEROZ has been successfully added to your 